Vaxcyte Inc (PCVX)

NASDAQ
45.04
+1.01(+2.29%)
  • Volume:
    400,731
  • Day's Range:
    43.73 - 45.50
  • 52 wk Range:
    16.78 - 47.63

PCVX Overview

Prev. Close
44.03
Day's Range
43.73-45.5
Revenue
-
Open
44.04
52 wk Range
16.78-47.63
EPS
-2.98
Volume
400,731
Market Cap
3.47B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,179,608
P/E Ratio
-14.81
Beta
1.12
1-Year Change
121.7%
Shares Outstanding
77,127,634
Next Earnings Date
Mar 27, 2023
What is your sentiment on Vaxcyte?
or
Vote to see community's results!

Vaxcyte Inc News

Vaxcyte Inc Company Profile

Vaxcyte Inc Company Profile

Employees
89

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

Read More

Analyst Price Target

Average62.20 (+38.25% Upside)
High70
Low52
Price44.99
No. of Analysts5
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyBuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
  • What happened? Why the price suddenly crash?
    0
    • Will this go up?
      1
      • Hello
        0